01.11.2012 Views

Table of Contents - Academy of Psychosomatic Medicine

Table of Contents - Academy of Psychosomatic Medicine

Table of Contents - Academy of Psychosomatic Medicine

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

50. Identification <strong>of</strong> Characteristics <strong>of</strong><br />

Providers that Influence Prescription<br />

<strong>of</strong> Analgesics for Patients With Pain: A<br />

Systematic Review <strong>of</strong> the Literature.<br />

Presenting Author: Lauren Franz, MBChB, MPH<br />

Co-Authors: Deepmala Deepmala, MBBS, Carolina Aponte<br />

Urdaneta, MD, Wei Jiang, MD<br />

Purpose: Pain is a co-morbid and aggravating symptom<br />

in many conditions which can be perceived differently, and<br />

therefore, managed differently. Numerous factors, in particular<br />

social and cultural factors, are thought to influence analgesic<br />

prescription. However, elucidation <strong>of</strong> such areas is limited.<br />

Therefore, we conducted a systematic literature review<br />

to test the hypothesis that variations in provider characteristics<br />

predict prescription <strong>of</strong> analgesics for patients with pain.<br />

Methods: A MEDLINE and Psychinfo database search from<br />

1960 to 2009 was conducted using the search terms <strong>of</strong> pain<br />

treatments, culture, ethnicity, race, gender, and physician<br />

practices. A total <strong>of</strong> 142 articles were initially identified, but<br />

only 12 articles were included in the final analysis following<br />

consensus by three independent reviewers based on inclusion<br />

criteria. For inclusion the studies needed to contain information<br />

on both provider demographic characteristics and<br />

analgesic prescription practices for pain in the analysis section<br />

<strong>of</strong> the paper.<br />

Results: Of the 12 studies, all were cross-sectional in design,<br />

and 10 used a survey instrument to measure quantitative<br />

responses. A randomized sampling methodology was<br />

used in 5 <strong>of</strong> the studies and a convenience sample was used<br />

in 4. A great heterogeneity existed among all the studies in<br />

terms <strong>of</strong> population, and purpose. A total <strong>of</strong> 3531 providers<br />

were identified among the 11 studies that presented data.<br />

The majority <strong>of</strong> providers who participated in these studies<br />

were male (64.9% in 8 studies that presented data), Caucasian<br />

(73.5% in 5 studies), internal medicine physicians and<br />

primary care providers (65.25% in 10 studies) and located<br />

in the United States (75% across all 12 studies). Of the 12<br />

studies 10 identified at least one provider characteristic that<br />

influenced prescription practices. Age, level <strong>of</strong> experience,<br />

and gender were listed most frequently as contributing factors.<br />

The interplay between the gender <strong>of</strong> providers and patient<br />

characteristics appeared to be an important variable in<br />

pain management as well.<br />

Conclusions: Our systematic review <strong>of</strong> existing literature<br />

highlights that a provider’s age, gender, experience, specialty<br />

and the interplay between provider and patient characteristics<br />

are important variables in pain management. We also<br />

found lacunae in the literature on the influence <strong>of</strong> physician’s<br />

ethnicity or primary medical training in various cultures or<br />

global regions on pain management practices. A homogeneity<br />

<strong>of</strong> provider pr<strong>of</strong>iles was noted, which limits generalizability<br />

<strong>of</strong> data from these studies. A systematic approach to evaluate<br />

the influence <strong>of</strong> provider’s characteristics on pain management<br />

is essential and imperative.<br />

21<br />

51. Encephalitis Associated with NMDA<br />

Receptor Antibodies<br />

Presenting Author: Abdul Khalid, MD<br />

Co-Author: David Straker, DO<br />

Background: Paraneoplastic encephalitis associated with<br />

N-methyl-D-aspartate receptor antibodies is a rare syndrome<br />

that should be considered in the differential diagnosis <strong>of</strong> a<br />

young, female patient with no prior psychiatric history who<br />

has a sudden change in mental status, exhibits bizarre behavior,<br />

and has prominent psychiatric symptoms accompanied<br />

by seizures, autonomic instability, hypoventilation and<br />

dyskinesias.<br />

Objective: The authors hope to increase the awareness <strong>of</strong><br />

such a syndrome as demonstrated in the case presented.<br />

Method: The authors report on a 20 year old previously<br />

healthy female with no past psychiatric history who presented<br />

with a sudden onset <strong>of</strong> change in behavior, mutism, agitation,<br />

staring spells, and dis-inhibited behavior, accompanied<br />

by seizures, hyperthermia and prominent autonomic instability.<br />

She also had muscle rigidity, frequent facial grimacing<br />

and kicking motions <strong>of</strong> the legs.<br />

Results: The patient was treated with anticonvulsant medication<br />

to control her seizures. She was then placed on high<br />

dose steroids with small improvement noted. Subsequently<br />

a vas cath was placed for plasmapheresis. IVIG was given<br />

and by Day 3 the patient was much more interactive with<br />

significant overall improvement by Day 5. The patient was<br />

discharged 3 days later. Two months after discharge the<br />

patient’s family reported that she was back to her baseline<br />

functioning.<br />

Conclusion: Paraneoplastic anti-NMDA receptor encephalitis<br />

is a potentially lethal syndrome, but is usually reversible<br />

if promptly recognized and treated. Early recognition and<br />

awareness can lead to appropriate treatment and resolution<br />

<strong>of</strong> symptoms.<br />

52. Disordered Eating in Schizophrenia and<br />

Superior Mesenteric Artery Syndrome - A<br />

<strong>Psychosomatic</strong> Case Study<br />

Presenting Author: Khyati Brahmbhatt, MD<br />

Co-Author: Geraldine Mayor, MD<br />

Purpose: The purpose <strong>of</strong> this poster is to analyze the relation<br />

between psychosis and disordered eating, demonstrate<br />

the relation <strong>of</strong> disordered eating to Superior Mesenteric Artery<br />

Syndrome (SMAS) and appreciate Confounding effects<br />

<strong>of</strong> Psychiatric diagnosis on medical care using a clinical case<br />

report.<br />

Methodology: Case report<br />

Introduction: SMAS is a form <strong>of</strong> upper intestinal obstruction<br />

caused by compression <strong>of</strong> the third part <strong>of</strong> the duodenum by<br />

the superior mesenteric artery due to loss <strong>of</strong> peritoneal fat.<br />

Most cases in psychiatry are related to Anorexia Nervosa.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!